NCT03840018 is a NA clinical trial of Letter by post to patients in Drug Overdose, sponsored by Osakidetza.

Who is sponsoring NCT03840018?

NCT03840018 is sponsored by Osakidetza.

What drugs are being tested in NCT03840018?

Interventions in NCT03840018: Letter by post to patients.

What condition does NCT03840018 study?

NCT03840018 studies Drug Overdose.

Is NCT03840018 still recruiting?

NCT03840018 is currently completed. Last updated 15 February 2019.

Last reviewed 2019-02-15 · How we verify

NCT03840018

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of a Postal Intervention to Improve the Use of PPI

Completed NA Last updated 15 February 2019

What this trial tests

NA trial testing Letter by post to patients in Drug Overdose in 401 participants. Completed in 18 April 2018.

Timeline

10 May 2017

Primary endpoint
10 December 2017

18 April 2018

Quick facts

Lead sponsor	Osakidetza
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	401
Start date	10 May 2017
Primary completion	10 December 2017
Estimated completion	18 April 2018
Sites	1 location across Spain

Drugs / interventions tested

Letter by post to patients

Conditions studied

Drug Overdose — all drugs for Drug Overdose →

Sponsor

Osakidetza

Who can join

18 and older, any sex, with Drug Overdose. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It was a randomised intervention study, with before-and-after outcome measures and a control group, in patients who had an active long-term prescription for PPIs at high doses for at least 6 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Drug Overdose

Currently open trials in the same condition.

NCT07193069 — Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning · recruiting
NCT06327061 — Social Network Overdose Prevention and Education Intervention · NA · recruiting
NCT05657106 — Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk · NA · active not recruiting
NCT05320835 — A Setting Focus Overdose Prevention Intervention · NA · recruiting

Other Osakidetza trials

Trials by the same sponsor.

NCT07474766 — BurnOutCare: WhatsApp Online Community for Burnout Prevention in Primary Care Professionals · NA · completed
NCT03043040 — Prevention of Suicidal Behaviour With Telemedicine Techniques · NA · completed
NCT01642394 — Impact of Self-care Education Program in Patients With Type 2 Diabetes in Primary Care in the Basque Country · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03840018 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Osakidetza
Last refreshed: 15 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03840018.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing